The reproductive capacity of the mammary epithelial stem cell is reduced coincident with the number of symmetric divisions it must perform. In a study of FVB/ N mice with the transgene, WAP-TGFb1, we discovered that mammary epithelial stem cells were prematurely aged due to ectopic expression of TGF-b1. To test whether premature aging of mammary epithelial stem cells would have an impact on susceptibility or resistance to mammary cancer, female littermates from FVB/ N6WAP-TGF-b1 mating were injected with mouse mammary tumor virus (MMTV) at 8 ± 10 weeks of age. A total of 44 females were inoculated, maintained as breeders and observed for tumor development for up to 18 months. Only one mammary tumor appeared in 17 TGF-b1 females while 15 were collected from 29 wild type sisters. Premalignant mammary epithelial cells in infected glands were identi®ed by transplantation of single cell (1610 5 ) suspensions into nulliparous hosts and testing for hyperplastic outgrowth. Although the number of positive takes was signi®cantly reduced with TGF-b1 cells, both MMTV-infected TGF-b1 and wild type cells produced hyperplastic outgrowths suggesting that premalignant transformation was achieved in each group. The results suggest a positive correlation between the procreative life-span of mammary epithelial stem cells and mammary cancer risk. Oncogene (2001) 20, 2264 ± 2272.
Introduction
Transforming growth factor-b1, is a member of a large superfamily of polypeptides that appears to aect many key events in normal growth and dierentiation (Massague, 1990; Sporn and Roberts, 1992) . Besides the four isoforms found in vertebrates, the family includes inhibins activins, bone morphogenic proteins, and related morphogenic peptides. Members of this superfamily are commonly expressed at sites of mesenchymal-epithelial interactions in organisms varying from¯ies to mice (Kingsley, 1994) . TGF-b1 was expressed under the control of the whey acidic protein (WAP) promoter. This promoter is mammary epithelium-speci®c and most active during late pregnancy and lactation. In this model no inhibition of mammary ductal growth at puberty was observed (Jhappan et al., 1993) . With the onset of pregnancy, lobulo ± alveolar growth and development was impaired to the extent that lactation was impossible. Subsequent transplantation studies demonstrated that this phenotype was intrinsic to the transgenic epithelium expressing WAP-driven TGF-b1 and that the eect was cis in nature, i.e. autocrine rather than paracrine (Kordon et al., 1995) .
Further analysis of the defect in lobular development in the WAP-TGF-b1 model revealed an increased rate of alveolar cell apoptosis in the transgenic glands. Alveolar cell mitosis, however, also continued at an increased rate over that observed in the normal control glands throughout pregnancy suggesting that autocrine TGF-b1 did not inhibit mammary alveolar proliferation (Kordon et al., 1995) . Thus, overexpression of TGF-b1 in dierentiating secretory mammary epithelial cells leads to premature programmed cell death. Another consequence of the WAP/TGF-b1 transgene expression was premature senescence of the mammary speci®c epithelial stem cells manifest in the signi®cant decreased capacity of WAP/TGF-b1 mammary transplants to grow suciently to repopulate a cleared normal fat pad (Kordon et al., 1995) . DeOme et al. (1959) demonstrated that virtually any portion of the mammary gland could recapitulate the entire glandular structure upon transplantation into a cleared mammary fat pad. Similar results are obtained with isolated mammary epithelial cells, although larger numbers of cells are generally needed due to technical considerations (Smith, 1996) . Age, parity and hormonal status of the donor does not alter the innate regenerative capacity present in the mammary epithelial population . However, regenerative senescence is induced by repeated serial passage of portions of the outgrowth (Daniel et al., 1968 . The rate of senescence for regenerative growth in serially-passaged outgrowths is strongly linked to the frequency of mitotic activity that has occurred in the transplant fragment that is selected. For example, fragments from peripheral portions of a given outgrowth, show a senescent growth phenotype at an accelerated frequency in serial transplants as compared to outgrowths of fragments taken from the central portions of the same outgrowth . Utilizing this technique, DeOme and others demonstrated that MMTV-induced premalignant mammary epithelial lesions were present in the mouse mammary gland DeOme et al., 1959; Medina, 1973; Smith et al., 1984) . Premalignant outgrowths do not show regenerative senescence or post-lactational involution and therefore represent epithelial populations that have attained or retained a proliferative`immortality'. In all likelihood, this characteristic is shared among all premalignant epithelial populations, irrespective of species or tissue type (Sell and Pierce, 1994) .
The MMTV life cycle begins with the ingestion of infected milk by the pups of a viremic mother (reviewed in Held et al., 1994; Ross, 1998) . A shortened gastric vein that empties into the superior hilus of the spleen has been implicated in the individual susceptibility of the pup because it insures the rapid transit of the infectious virus to susceptible lymphoid cells in the spleen (Roubinian and Blair, 1980) . After a few days the virus infects B cells in lymphoid tissue of the gut e.g. Peyer's patches. In addition to the gag, pol, and env proteins commonly encoded by retroviral genomes, the U3 region of the long terminal repeat (LTR) of MMTV encodes a protein designated, superantigen (Sag). Sags are presented on the cell surface by major histocompatiblity (MHC) class II proteins in antigen-presenting cells (APCs) such as B cells. The Sag causes the proliferation of cognate T cells, which in turn stimulate bystander B cell proliferation. This develops a reservoir of infectioncompetent cells from which MMTV spreads to other lymphocyte subsets (CD4 + and CD8 + cells) during the following weeks. Deletion of Sag reactive T cells is detected during the ®rst 2 months of life and seems to have no impact on the health of the animal.
Infected lymphoid cells play a critical role in the infection mammary epithelial cells. Whether the virus is transferred by cell ± cell contact or whether infected lymphoid cell represents a vehicle to deliver virus to the mammary gland is unknown. It is known that MMTV infection also occurs in a variety of other epithelial tissues, including salivary gland, kidney, lung, seminal vesicle, epididymis and testis (Imai et al., 1994) . Presumably, all of these tissues are infected in the same way as the mammary gland. Nevertheless, with few exceptions (Felluga et al., 1969) only the mammary epithelium is malignantly transformed subsequent to infection and replication of MMTV. This suggests that mammary epithelium and MMTV share a unique relationship, since proviral insertion (hence, mutation) and viral replication are inseparable. The key to this puzzle seems to be the regenerative activity of the mammary epithelium as compared to the other comparably infected tissues. For example, the epithelium in the mammary gland increases roughly 30-fold each pregnancy only to shrink a like amount following the cessation of lactation during involution (Kordon and Smith, 1998; Nicoll and Tucker, 1965) . In all MMTV-infected strains the rate and frequency of mammary tumorigenesis is increased by multiple pregnancy cycles (DeOme et al., 1978a,b; Squartini et al., 1983) . This by itself does not completely explain the occurrence of neoplastic transformation in the mammary epithelium because nearly all of the MMTVinfected cells die by apoptosis at involution. The explanation may be the presence and persistence of multipotent mammary stem cells that are self-renewing and subject to infection by MMTV (Kordon and Smith, 1998) . It is these MMTV-infected cells which persist and acquire further mutations that give rise to MMTV-induced hyperplasia and tumors.
In earlier experiments, MMTV was introduced through the mother's milk or genetically as a dominantly expressed proviral DNA copy. In all cases, MMTV-induced mammary tumorigenesis proceeded unabated in WAP-TGF-b1 mice (Buggiano et al., 2001) . This result suggested that MMTV remained eective as a tumorigenic agent, despite the severe reduction in alveolar development and increased alveolar cell apoptosis in pregnant WAP-TGF-b1 females (Kordon et al., 1995) . In the present work we have investigated whether the premature aging of mammary epithelial stem cells observed in the postpubescent mammary glands of WAP-TGF-b1 would impact on the frequency of MMTV-induced mammary tumorigenesis. Therefore, MMTV was introduced into mature (3 ± 5-month-old) female FVB/N wild type and WAP-TGF-b1 littermates. These mice were subsequently set up as breeders and observed for mammary tumorigenesis.
Results

Mammary stem cell senescence in WAP-TGF-b1 mice
In our initial studies with WAP-TGF-b1 (B + ) mammary epithelium, we observed that B + epithelial cells or fragments were far less able to grow and repopulate epithelium-divested mammary fat pads than wild type FVB/N (WT) mammary cells (Kordon et al., 1995) . These results were interpreted as evidence for the premature senescence of mammary epithelialspeci®c stem cells in the B + glands. An alternative interpretation, namely, that expression of the transgene in the growing implant resulted in slowed growth was ruled out, because WAP promoter expression is exquisitely hormone-dependent and occurs only in the dierentiating secretory epithelium of pregnant females and transiently in scattered individual luminal epithelial cell in cycling virgin females at estrus. We repeated these experiments with both MMTV-infected and uninfected B + and WT mammary epithelium. Equivalent results were obtained from implants of mammary fragments or isolated mammary epithelial cells (2 ± 3610 5 ). The results of these transplant experiments are shown in Table 1 . The number of positive takes that grew to ®ll 50% or more of the empty fat pads compared to the total number of implants are given for each group. No dierence in the number of implants able to grow and ®ll cleared mammary fat pads was observed when they were taken from 3-week-old B + or WT pre-pubertal mammary glands. However fragments or cells from post-pubertal, 3 ± 5-month-old B + females were often unable to grow and ®ll 50% of the fat pad compared to implants from wild type donors. This disparity in clonogenic activity increased with age and parity in the B + mammary glands and was not aected by the presence of MMTV. As noted in our earlier experiments, the growth senescence observed in B + mammary epithelium appeared subsequent to the onset of puberty and the estrus cycle (Kordon et al., 1995) . A signi®cant number of implants from 3 ± 5-month-old B + females failed to grow and ®ll the fat pad. Only nine of 22 (no MMTV) and 10 of 26 (+MMTV) B + implants were able to ®ll 50% or more of the fat pad, whereas 24 of 24 (no MMTV) and 24 of 26 (+MMTV) WT implants successfully ®lled the fat. Still fewer B + implants, ®ve of 20 (no MMTV) and eight of 31 (+MMTV), grew to occupy 50% of the cleared pad when taken from 12 ± 15-month-old breeding females. On the other hand, wild type implants from similarly aged breeders ®lled 16 of 20 (no MMTV) and 19 of 24 (+MMTV) implanted fat pads. Therefore when MMTV was introduced at 3 ± 5 months of age, the B + mammary glands had begun to exhibit premature senescence of mammary epithelial stem cells, whereas WT gland did not.
Mammary tumorigenesis in MMTV-infected WAP-TGF-b1 mice
Female mice expressing TGF-b1 from the WAP promoter exhibit two concomitant and distinct mammary phenotypes. The most obvious trait is the incomplete development of a functional secretory gland during pregnancy due to programmed cell death in the dierentiating lobular epithelium (Kordon et al., 1995) . A second less apparent phenotype was the early reduction of regenerative potential in the mammary clonogenic stem cells as measured by transplantation analysis. We interpret this as evidence for premature aging of the mammary epithelial stem cells (Kordon et al., 1995) . Tumorigenesis by MMTV is associated with the development of premalignant alveolar lesions (HAN) which subsequently develop into focal mammary tumors (DeOme et al., 1959) . Buggiano et al. (2001) introduced several dierent strains of MMTV into B + females to assess the tumorigenic response of their poorly developed mammary epithelium. There was no dierence in the susceptibility to infection with MMTV, tumor induction or ®nal tumor incidence in WAP-TGF-b1 (B + ) females compared to their wild type (WT) sisters. In these experiments MMTV was introduced perinatally. We wished to test the eect of the second mammary phenotype, i.e., a reduced clonogenic capacity, upon MMTV-induced tumorigenesis. Therefore, we introduced MMTV into mature virgin females whose mammary gland epithelium had already begun to exhibit reduced clonogenic capacity as determined by transplantation (Kordon et al., 1995) . MMTV was introduced into littermate WT and B + FVB female mice 3 ± 5 months postpartum by injecting 2610 6 Mm5MT cells into the peritoneum. All mice were injected with cells and concentrated culture¯uid from the same tissue culture passage to ensure equivalence in virus titer. The injected females were immediately placed with males and maintained as breeders throughout the duration of the experiment. Figure 1 shows the tumor incidence and the latency to tumor development for these females. A total of 46 females were inoculated and all survived beyond the average age of tumor appearance. Of the injected littermates, 17 were positive for the WAP-TGFb1 transgene and 29 were not. We found 15 tumors in WT littermates compared to only one in B + mice. The average age of tumor appearance was 16.9 months about 1 year after injection. The earliest tumor was observed at 12 months of age in a B + female. It was the only mammary tumor observed in the B + littermates. The last tumor was recovered from a 20-month-old WT female. Comparably aged WT and B + breeders (no MMTV) were maintained for the same amount of time. There were no tumors observed. The experiment was terminated when the oldest female reached 2 years of age. These results indicate that B + females are more resistant to MMTV-induced mammary tumorigenesis than their WT sister's.
Testing infected glands for inapparent transformed epithelial cells
MMTV induces premalignant lesions in infected glands commonly referred to as hyperplastic alveolar nodules (HAN). These lesions occur at increasing frequency following multiple gestation cycles. Examination of whole mounts of infected mammary glands from WT *Ability to repopulate a cleared fat pad (450% ®lled fat pads/ number of transplants6100). A transplant was considered positive if at least 50% of the total fat was ®lled with mammary epithelium. In most of the negative TGF-b1 transplants less than 20% of the pad was ®lled. The wild type implants generally were able to ®ll the pads to at least 85% of their volume, with the exception of implants from multiparous females which were somewhat less vigorous. Fisher's exact test was applied to each of the groups. There was no dierence between implants from prepubertal (3-week-old) donors. Comparison of implants from 3 ± 5 month and 12 ± 15 month old donors gave P values of 0.0001 and 0.00012, respectively and B + revealed the presence of HAN's ( Figure 2A ,B). The frequency of HAN's was signi®cantly greater in the WT glands as compared to B + glands (data not shown). HANs represent alveolar lesions that appear subsequent to pregnancy because they resist involution following cessation of lactation. During pregnancy, B + glands develop only very small alveolar buds and fail to lactate. Hyperplastic alveolar nodules are detected in whole mounts of involuted glands. They are identi®ed as local accumulations of persisting secretory lobules. Because TGF-b1 expression in dierentiating secretory cells causes their apoptosis, consequently, the size of HAN in involuted B + glands may be signi®cantly smaller. Therefore the number of premalignant lesions that are observable in B + whole mounts might be underestimated. Inapparent-transformed MMTV-infected cells were detected by dissociation of MMTVinfected B + and WT glands to single cells and subsequently inoculating them (1610 5 ) into the cleared fat pads of syngeneic female hosts (DeOme et al., 1978a,b) . The resulting outgrowths were scored for hyperplastic versus normal growth following 12 ± 16 weeks in nulliparous hosts (Table 2) . From MMTVinfected WT single cell implants, 25/36 (69.4%) produced epithelial growths. Of these, 16 (64%) had mixed hyperplastic alveolar or tumor growth ( Figure  3A ) and 9 (36%) were normal ductular outgrowths. In single cell preparations from B + glands, 8/21 (38%) had epithelial growth. Of these, none were tumors and only one showed mildly hyperplastic growth ( Figure  3B ). Similar experiments were done with single epithelial cell suspensions from uninfected WT and B + control glands. The dierence in the percentage of positive takes was similar that observed for the infected cells. WT cells produced 9/12 positive takes (75%) and B + produced 6/12 (50%). No atypical or hyperplastic growth was observed (not shown). As observed in earlier transplantation studies, B + implants often failed to ®ll 50% of the fat pad (Kordon et al., 1995) .
Evidence of MMTV infection and integration in WT and B + mice
To ensure B + and WT females were equivalently infected with MMTV, we subjected histological sections cut from paran blocks of B + and WT mammary glands from tumor-bearing and tumor-free females. Viral-speci®c immunoperoxidase staining was present among the epithelial cells in HANs and also those in normal ducts and acini throughout the glands of both WT and B + females (Figure 4 ). Sections from MMTV-induced tumors were also strongly positive for MMTV-speci®c antigens by immunoperoxidase (not shown). At the completion of the experiment, somatic cell DNA was isolated from all the tumors that were collected and from the pooled spleens from MMTVinfected B + and WT females that had survived tumorfree. Polymerase Chain Reactions (PCR) with primers speci®c for viral sequences present uniquely in MMTV (C3H) were performed to detect the presence of integrated MMTV (C3H) provirus within the tumor and lymphocyte DNA ( Figure 5 ). The speci®c MMTV (C3H) 3.0 Kb product was detected in all of the MMTV (C3H)-infected mice but was not detected in DNA isolated from uninfected control animals of the same genotype or in tissue infected with MMTV (Czech) virus. In Figure 5A Figure 5b , DNA from lactating MMTV (Czech) virus-infected mammary gland and uninfected lactating WT mammary gland produced no 3.0 Kb product, whereas DNA from three independent MMTV (C3H)-induced WT mammary tumors was strongly positive. Arrowheads indicate MMTV (C3H)- Figure 1 This graph shows the rate of mammary tumor formation and the ®nal tumor incidence over an observation period of 80 weeks. Tumor incidence over time is shown for wild type FVB/N females with (®lled circles) and without (®lled squares) infection with MMTV and WAP-TGF-b1 transgenic FVB/N females with (®lled triangles) and without (un®lled squares) infection with MMTV. No tumor formation was observed in either 2-month-old uninfected WT or TGF-b1 breeders that were kept for an additional 80 weeks (30 females each). In contrast, a 51.7% mammary tumor incidence was found in MMTV-infected wild type FVB/N breeders (15/29), but only one tumor (5.8%) was found in MMTV-infected TGF-b1 breeders (1/17) speci®c PCR-ampli®ed DNA (3.0 Kb). These tests demonstrate that both the B + and WT mice were successfully infected with MMTV (C3H) upon injection of the Mm5MT cells.
Discussion
It has recently been shown that the progeny from a single cell may comprise the epithelial population of a fully developed lactating mammary outgrowth in mice (Kordon and Smith, 1998) . Serial transplantation of epithelial fragments from this clonally-derived transplant demonstrates that the subsequently generated outgrowths are also comprised of progeny from the original antecedent. All epithelial cell types were found to be present within these clonally regenerated normal populations including luminal, myoepithelial, duct/ lobule-committed epithelial progenitors and fully competent mammary epithelial stem cells. These observations demonstrate the uniform presence of multipotent tissue-speci®c epithelial stem cells among the parenchyma of the murine mammary gland. Therefore regeneration of the mammary epithelium upon transplantation requires that symmetric division of the pre-existing stem cell(s) occur at regular intervals along the extending ducts in order to preserve the regenerative capacity of all portions of the mammary tree. It has been demonstrated previously that reproductive senescence of these multipotent precursor cells is predicated upon mitotic activity (Daniel et al., 1968 . Estimation of the total number of symmetric divisions that the progeny from a single mammary epithelial stem cell must undertake in these transplantation studies indicates that 44 ± 45 doublings are possible (Kordon and Smith, 1998) . Here, we have demonstrated that reduction of the reproductive life span of multipotent mammary epithelial stem cells in situ results in a signi®cant protection from susceptibility to MMTVinduced mammary tumorigenesis.
In an earlier set of experiments, the consequence of impaired survival of dierentiating lobulo-alveolar cells in WAP-TGF-b1 females and susceptibilty to MMTVinduced mammary tumorigenesis was examined (Buggiano et al., 2001) . In these studies, MMTV was introduced into WT and B + littermates at birth by foster-nursing on MMTV-infected mothers. Alternatively, MMTV was introduced into all the pups by crossing WAP-TGF-b1 females with GR strain males that are homozygous for a dominantly expressed MMTV provirus gene (mtv-2). Mtv-2 encodes a fully infectious, tumorigenic MMTV. Tumorigenesis in mtv-2 bearing females is 100% within one year of age (Van Nie et al., 1977) . Of interest, in all of the B + tumors tested (n=6), the WAP transgene was transcriptionally active, suggesting that tumorigenesis was not aected by the presence of active TGF-b1. In these experiments, B + littermates were equally susceptible to MMTV-induced tumorigenesis as their WT sisters. This result clearly repudiates the notion that MMTV + breeders injected with MMTV or uninfected control females, were inoculated into epithelium-divested mammary fat pads of 3-week-old FVB/N virgin females. The implants were allowed to grow for 12 ± 16 weeks before removal and whole mount analysis. females, who were subsequently bred, a signi®cant reduction in mammary tumor incidence was observed in the B + females as compared to their WT littermates. This disparity in mammary tumor susceptibility seems most logically explained as resulting from the reduced clonogenic and reproductive capacity associated with B + mammary parenchyma, and that this is manifest in the reduced capacity of mammary epithelial stem cells. An alternative explanation is that the growth rate of B + mammary epithelial cells is reduced in the transplants, giving the impression of senescent growth, when actually it represents slower growth because of the presence and expression of the transgene. This is unlikely for two reasons, ®rst, observation of the B + outgrowths for periods up to one year does not result in additional ductal growth; second, WAP promoter activity is essentially nil in the nulliparous female, except transiently at estrus. Moreover, WAP promoter expression is restricted to individual luminal cells of the subtending ducts in cycling virgin mice as is never found in the terminal end bud, the site of glandular growth and extension.
Our results and those of Buggiano et al. (2001) show that MMTV can infect and also transform B + mammary epithelium. The distinction between our respective results is the frequency of transformation and progression to malignancy that occurs in B + females infected with MMTV later in mammary development as compared to those infected at birth. An apparent explanation of this paradox is the distinction that exists between the ability of premature and mature B + mammary glands to fully reconstitute mammary epithelial outgrowths upon transplantation to syngeneic epithelium-divested mammary fat pads. This suggests that as a population, B + mammary epithelium is capable of fewer mitotic divisions than WT and therefore has a lower growth potential. MMTV is a non-acute transforming retrovirus, i.e., MMTV causes mutations by random insertion of viral DNA copies into the infected cell genome. These genome insertions are dependent upon the cell cycle. The frequency of this event, and the ®xation of other mutations, is dependent upon the frequency that the aected cell traverses the cell cycle. Thus, reducing the reproductive capacity of the mammary epithelium serves to reduce the frequency with which transforming mutations may occur and be ®xed in the population whether they arise from insertion, reduplication, inversion or deletion. The importance of the mammary epithelial stem cell in mammary gland growth, development, function and regeneration has been abundantly supported in recent studies from mouse, rat and human. The fraction of mammary cells capable of clonogenic epithelial growth in vivo in the rat and mouse has been experimentally determined to be roughly 1 : 1000. In addition, multipotent cells with distinctly dierent ontogenetic abilities have been de®ned. For example, the existence of mammary progenitors uniquely committed to duct versus lobule morphogenesis and vice versa has been established (Kamiya et al., 1999; Smith, 1996) . These lineagelimited progenitors are progeny from a fully competent mammary epithelial precursor (Kordon and Smith, 1998) . The evidence from transplantation studies of B + mammary epithelium suggests that it is this fully competent precursor that is aected subsequent to the onset of TGF-b1 expression in the glands of postpubertal mice. Because both ductal and lobular development are curtailed in the B + outgrowths (Kordon et al., 1995) and later transplantation studies with B + mammary cells from primary culture indicated that growth from both lobule-committed and ductcommitted was equivalently reduced (Smith, unpublished result). Therefore, TGF-b1 expression from the WAP promoter subsequent to the onset of puberty results in the reduction of the self-renewing capacity of mammary epithelial stem cells throughout the mammary gland.
TGF-b1 expression from the MMTV-LTR-promoter (Pierce et al., 1995) has been shown previously to suppress mammary tumorigenesis in MMTV-TGF-b1 and MMV-TGF-b1/MMTV-TGF-a transgenic mice exposed to the chemical carcinogen, 7,12-dimethylbenz [a]anthracene (DMBA). These authors proposed that TGF-b inhibits proliferation of epithelial cells and also suppresses the early stages of carcinoma development. In WAP-TGF-b mice, we determined that alveolar epithelial cell division was not inhibited throughout pregnancy, on the contrary, it persisted longer due to the secretory cell apoptosis induced by the expression of WAP-TGF-b1. Instead, WAP-TGF-b1 epithelium loses its ability to repopulate mammary fat pads when transplanted. The ability of MMTV-TGF-b1 expressing mammary epithelium to repopulate cleared mammary fat pads after transplantation was not tested. Nonetheless, the resistance of MMTV-TGF-b1 mice to the induction of mammary tumors is consistent with the concept that early stem cell senescence may also play an important role in the suppression of tumor susceptibility in these studies. Also of interest is the report that autocrine TGF-b suppresses telomerase activity and transcription from the human telomerase reverse transcriptase gene (HTERT) in colon carcinoma cells in vitro (Yang, 2000) . A similar activity was ascribed to exogenous TGF-b1, when added to A549 human lung carcinoma cells in vitro (Katakura et al., 1999) .
Our current understanding of multipotent stem cells in tissue regeneration and replacement is undergoing a rapid advancement. Developing our knowledge of the biological and molecular cues that signal stem cells to endure, to function and/or to desist is central to our development of means to control them toward our own best interests.
Materials and methods
Mice
WAP-TGF-b1 transgenic (Jhappan et al., 1993) and FVB/N mice were both used as hosts and donors. They were housed in a closed colony on 12 h light 12 h dark cycle under controlled temperature and humidity. They were fed standard lab chow and given water ad libitum. Autoclaved hardwood bedding was used.
Propagation of infectious MMTV and infection of the mice
Mm5MT, passage 17 cells were purchased from American Type Cell Cultures (ATCC, Rockville, MD, USA). And propagated in Dulbecco's Modi®ed Eagle Medium, 10% fetal calf serum with 10 mg/ml insulin added. This cell line was derived from an MMTV-induced C3H mouse mammary tumor and has been used extensively as a source of tissue culture-derived infectious MMTV (Arthur et al., 1978) . The mice were inoculated intraperitoneally with 2610 6 Mm5MT cells and their concentrated tissue culture medium. All mice were inoculated with cells and medium from the same tissue culture passage. Presence of numerous MMTV particles associated with the Mm5MT cells was con®rmed by electron microscopy.
Single cell dissociation procedure
Our procedure was only slightly modi®ed from that published by DeOme et al. (1978a) . Two inguinal (#4) mammary glands were aseptically removed from each donor mouse. They were rinsed in DMEM (Gibco/BRL Gaithersburg, MD, USA) and weighed. Glands were minced into very ®ne pieces with scalpels and placed in 250 ml Erlenmeyer¯asks containing 20 ml DMEM with 0.1% collagenase (Worthington Biochemical Corp; Freehold, NJ, USA; Type III approx 100 u/ ng) and 0.1% hyaluronidase (Sigma Chemical Co St. Louis, MO, USA; Type I 360 u/ng) per gram of tissue. The¯asks were then swirled at 120 r.p.m. at 378C for approximately 90 min until the suspensions were cloudy. Samples were then placed in 50 ml conical tubes and spun for 5 min at 1200 r.p.m. The fatty top layer and pellet were collected in DMEM with 1.25% pronase (Calbiochem B grade 45 000 proteolytic u/g), 10 ml per gram of original tissue. They were then shaken an additional 15 min at 378C. The suspensions were then spun and pelleted as above. The pellet was washed twice in 10 ml DMEM and then resuspended in 10 ml DMEM. If the resuspended cells looked threadlike, two drops of 0.2% DNase (Worthington 1200 u/ng) were added and then incubated at room temperature for 5 min. The cells were again pelleted and resuspended in 10 ml DMEM. They were then ®ltered through 40 um nylon cell strainers (Falcon 2340) Viability was determined by staining with Trypan blue. The number of live cells was typically 70% of the total suspension. Cells were spun down again and resuspended in appropriate amount of media for injection into host mice.
Cell injections and tissue transplantation
The surgical techniques used to clear the mammary epithelium from the #4 fat pad of 3-week-old host mice, and the subsequent transplantation of tissue fragments or cell suspensions was ®rst described in earlier publications (Daniel et al., 1968; DeOme et al., 1959; Medina, 1973; Smith et al., 1984) . Brie¯y, the mice were anesthetized IP with 26avertin diluted 1 : 80 in phosphate-buered saline, pH 7.2 (PBS). The clearing procedure was generally performed immediately prior to insertion of the transplanted fragment or cell suspension. Animals could however, be cleared and used at a later date. Removal of the fat pad from the lymph node to the nipple and complete separation from the #5 fat pad will ensure proper`clearing' and prevent interference from host. Transplanted tissues are approximately 1 ± 2 mm in size. They are implanted into a`pocket' made with jeweler's forceps. Cell suspensions are implanted in 10 ml volumes with a Hamilton syringe. Wound clips are used to close skin and the mice were recovered on heating pads. The implanted females were maintained as nulliparous mice. The implants were allowed to grow for 12 ± 16 weeks before removal and analysis in whole mount preparations (Rasmussen et al., 2000) .
Detection of MMTV C3H viral integration by PCR and Southern blot analysis
Speci®c primers were designed from the nucleotide sequence map of MMTV (C3H) (Hook et al., 2000) . The forward primers is in a region that shares homology with other forms of the virus, but the reverse primer is in a conserved region making it speci®c for C3H. Both are 21 mers and yield a 3000 bp fragment by PCR. The forward primer, DG 43 is: 5'-TGCCGGCCTGCAGCAGAAAT-3'. The reverse primer, 2321 ± 2300R is: 5'-ATACTTTTGTCCTCTCATGGC-3'. The product was ampli®ed from genomic DNA extracted from excised glands and or tumors using TRIzol reagent (Gibco/BRL) per manufacturer's protocol. Platinum Supermix (Gibco/BRL) was used with an annealing temperature of 558C for 35 cycles in a MJ Research Peltier Thermal Cycler. The products were separated by electrophoresis in 0.8% agarose at 50 volts overnight. Gels were then Southern blotted (Southern, 1975) . Transfer was done by capillary action overnight onto BrightStar-Plus (Ambion, Austin, TX, USA) nylon membrane. The membrane was hybridized with a randomly primed 32 P-labeled probe using the Megaprime DNA Labeling Kit (Amersham Pharmacia Biotech). The probe was a full-length MMTV-C3H PCR product (3 kb), ampli®ed from the DNA of Mm5MT-C3H cells described above. The membrane was hybridized overnight at 428C in ULTRAhyb buer (Ambion), and washed as directed by the manufacturer. The blot was exposed to autoradiography ®lm and the results analysed.
Immunoperoxidase staining
Five micron-thick paran sections were cut from blocks of Carnoy-®xed mammary glands and tumors, deparanized, hydrated and then blocked. First they were treated for 10 min in 0.3% hydrogen peroxide in methanol to destroy endogenous peroxidase activity, and then blocked in 20% goat serum and 0.1% bovine serum albumin (BSA). The sections were then incubated with MMTV-speci®c R168 antibody, a gift from Dr Larry Arthur (NCI, Frederick, MD, USA). The speci®city of this antibody for MMTV has been previously described (Arthur et al., 1978) . The slides were washed in PBS and then exposed to biotinylated, Goat antirabbit gamma-globulin-speci®c antiserum. Positive immunostaining was revealed by an Avidin ± Biotin detection kit (Elite, Vector Laboratories, Inc.) protocol as described previously (Heine et al., 1987) . Controls included omission of the primary antibody, and the simultaneous use of MMTV-free negative tissue samples.
